Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief for common chronic health conditions in the elderly for the physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'an, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.
IPO Year: 2021
Exchange: NASDAQ
Website: dzrzy.com
| Date | Price Target | Rating | Analyst |
|---|
SC 13G/A - Universe Pharmaceuticals INC (0001809616) (Subject)
SC 13G - Universe Pharmaceuticals INC (0001809616) (Subject)
SC 13G - Universe Pharmaceuticals INC (0001809616) (Subject)
6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
6-K - Universe Pharmaceuticals INC (0001809616) (Filer)
424B4 - Universe Pharmaceuticals INC (0001809616) (Filer)
EFFECT - Universe Pharmaceuticals INC (0001809616) (Filer)
F-1/A - Universe Pharmaceuticals INC (0001809616) (Filer)
Jiangxi, China, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ:UPC) ("Universe Pharmaceuticals" or the "Company"), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of 15 ordinary shares with par value of US$0.01875 per share each in the Company's issued and unissued share capital into one (1) ordinary share with par value of US$0.28125 (the "Share Consolidation"). As a result of the Share Consolidation, each 15 pre-consolidation ordinary shares outstanding will automatically combine and convert to one issued and outstanding ordinary share without any action on the part of the shareholders.
Ji'an, Jiangxi, China, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on October 25, 2024, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price
JI'AN, Jiangxi, China, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company," "we," "our" and "us") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2024 ended March 31, 2024. Mr. Gang Lai, Chairman of the Board of Directors and CEO of Universe Pharmaceuticals INC, commented, "During the first six months of fiscal year 2024, we navigated business uncertainties and adjusted our business strategy to offset the impact of the global economic slowdown. As a result, we generated $12.9 million in revenue for the six months ended March 31, 2024, lower than the $18.5
JI'AN, China, Jan. 30, 2024 /PRNewswire/ -- Universe Pharmaceuticals INC ("Universe Pharmaceuticals" or the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced its financial results for the fiscal year ended September 30, 2023. Mr. Gang Lai, Chairman and Chief Executive Officer of Universe Pharmaceuticals, commented, "Despite market fluctuations and the economic slowdown impacting our business in fiscal year 2023, we continued our efforts to deliver high quality products to our loyal customers. Our dedication to addressing the physical conditions of the elderly and promoting their longevity and general well-being remains unwavering. We maintain a pos
Jiangxi, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ:UPC) ("Universe Pharmaceuticals" or the "Company"), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on August 1, 2023, notifying the Company that it is not in compliance with the minimum Market Value of Publicly Held Shares ("MVPHS") requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq Global Market. Nasdaq Listing Rule 5450(b)(1)(C) requires listed securities to maintain a MVPHS of at least $5,000,000, and Nasdaq Listing Rule 5810(
Jiangxi, China, July 27, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ:UPC) ("Universe Pharmaceuticals" or the "Company"), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of six (6) ordinary shares with par value of $0.003125 per share each in the Company's issued and unissued share capital into one (1) ordinary share with par value of US$0.01875 (the "Share Consolidation"). As a result of the Share Consolidation, each six (6) pre-consolidation ordinary shares outstanding will automatically combine and convert to one issued and outstanding ordinary share without any action on the part of the sharehol
Ji'an, Jiangxi, China, March 07, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on March 2, 2023, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requ
Ji'an, Jiangxi, China, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that six varieties of the Company's products were included in the First Edition of Catalogue of Medicine for Patients Infected with COVID-19 (the "Catalogue"), which was published by Beijing Health Commission on December 12, 2022. The included products are Banlangen Granules, Strong Loquat Extract, Pediatric Paracetamol, Vitamin C Yinqiao Tablets, Acetaminophen Tablets and Metamizole Sodium Tablets. The Catalogue supplements the list of recommended medicine in the Ninth Edition of the National Diagnosis and
Ji'an, Jiangxi, China, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the "Notification Letter") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") on November 9, 2022, informing the Company that it has regained compliance with the Nasdaq's minimum bid price requirement and the matter is closed. On July 15, 2022, the Company was notified by Nasdaq its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive business days under Nasdaq Listing Rules 5450(a)(1) and 5810(c)(3)(
JI'AN, China, Aug. 16, 2022 /PRNewswire/ -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2022 ended March 31, 2022. Mr. Gang Lai, Chairman and CEO of Universe Pharmaceuticals INC, commented, "During the first six months of fiscal year 2022, we have navigated business uncertainties and adjusted our business strategy to offset the impact of reduced product sales volume due to the resurgence of COVID-19 cases and related lockdowns. As a result, we generated $24.2 million in revenue for the six months ended March 31, 2022, slightly lower than t
Ji'an, Jiangxi, China, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company appointed Mr. Baochang Liu as its Chief Operating Officer, effective December 1, 2021. Mr. Baochang Liu has over 17 years of experience in pharmaceutical marketing. Mr. Baochang Liu has been working as the vice president of marketing and general manager of OTC department at China Shineway Pharmaceutical Group Ltd. since December 2019. Mr. Baochang Liu served as the general manager of OTC department at Chengdu Kanghong Pharmaceutical Group Co., Ltd. from November 2015 to December 2019. Prior
Shares of Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) fell sharply during Friday's session after the company announced pricing of $6.0 million public offering. Kaival Brands priced its 3,921,500 unit offering at $15.3 per unit. Kaival Brands Innovations Group shares dipped 47% to $1.52 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers American Rebel Holdings, Inc. (NASDAQ:AREB) shares jumped 161% to $0.8048 after the company signed a Connecticut distribution agreement with Dichello Distributors. Sharecare, Inc. (NASDAQ:SHCR) jumped 74% to $1.35 after the company agreed to be acquired by Altaris affiliate for $1.43 per share in cash.
Shares of GameStop Corp. (NYSE:GME) fell sharply during Friday's session after the company released worse-than-expected first-quarter results before schedule and filed to sell up to 75 million shares. GameStop released its first-quarter 2024 results early Friday ahead of its scheduled June 11 date. The company reported net sales of $881.8 million, down from $1.237 billion year-over-year. The net sales total missed a consensus estimate of $995.3 million. The company reported a loss of 12 cents per share, missing the estimate of a loss of 9 cents per share, according to data from Benzinga Pro. GameStop shares dipped 22.5% to $36.07 on Friday. Here are some other stocks moving in today
Gainers Acrivon Therapeutics (NASDAQ:ACRV) stock rose 12.3% to $10.67 during Wednesday's after-market session. The market value of their outstanding shares is at $329.4 million. Amarin Corp (NASDAQ:AMRN) stock moved upwards by 8.12% to $0.95. The company's market cap stands at $381.2 million. Universe Pharmaceuticals (NASDAQ:UPC) stock rose 7.47% to $2.3. The market value of their outstanding shares is at $8.3 million. China Pharma Holdings, Inc. Common Stock (AMEX:CPHI) shares moved upwards by 7.14% to $0.34. Telesis Bio (NASDAQ:TBIO) shares moved upwards by 7.12% to $0.34. The company's market cap stands at $10.3 million. Aesthetic Medical Intl (NASDAQ:AIH) shares moved upwards by 6.
Gainers Etao International Co (NASDAQ:ETAO) stock moved upwards by 96.6% to $4.9 during Monday's regular session. The company's market cap stands at $25.0 million. Longeveron (NASDAQ:LGVN) shares moved upwards by 48.63% to $3.27. The market value of their outstanding shares is at $8.2 million. Adlai Nortye (NASDAQ:ANL) stock rose 47.3% to $12.21. The market value of their outstanding shares is at $450.3 million. Onconetix (NASDAQ:ONCO) stock moved upwards by 26.56% to $0.21. The company's market cap stands at $4.6 million. MSP Recovery (NASDAQ:LIFW) stock rose 24.42% to $1.63. The market value of their outstanding shares is at $24.1 million. Outset Medical (NASDAQ:OM) shares moved upwa
Gainers Candel Therapeutics (NASDAQ:CADL) shares moved upwards by 64.3% to $2.76 during Thursday's regular session. The market value of their outstanding shares is at $80.9 million. TC BioPharm (Holdings) (NASDAQ:TCBP) shares increased by 61.38% to $2.1. The market value of their outstanding shares is at $5.0 million. Eiger BioPharmaceuticals (NASDAQ:EIGR) shares moved upwards by 38.18% to $2.28. The company's market cap stands at $3.3 million. Macrogenics (NASDAQ:MGNX) stock rose 32.55% to $18.12. The company's market cap stands at $1.1 billion. Barinthus Biotherapeutics (NASDAQ:BRNS) shares increased by 29.55% to $3.77. The company's market cap stands at $146.7 million. Curis (NASDAQ
Gainers Aesthetic Medical Intl (NASDAQ:AIH) shares rose 14.0% to $0.52 during Wednesday's after-market session. The company's market cap stands at $24.9 million. Kineta (NASDAQ:KA) shares rose 8.46% to $0.58. The company's market cap stands at $6.3 million. Simulations Plus (NASDAQ:SLP) shares increased by 6.74% to $40.99. The market value of their outstanding shares is at $818.4 million. As per the news, the Q2 earnings report came out today. Bolt Biotherapeutics (NASDAQ:BOLT) shares moved upwards by 6.66% to $1.44. The company's market cap stands at $54.9 million. Eiger BioPharmaceuticals (NASDAQ:EIGR) shares increased by 6.66% to $1.76. The market value of their outstanding shares is
Gainers Stoke Therapeutics (NASDAQ:STOK) shares increased by 77.7% to $11.55 during Monday's after-market session. The company's market cap stands at $515.7 million. As per the news, the Q4 earnings report came out today. OpGen (NASDAQ:OPGN) shares moved upwards by 66.61% to $0.79. The market value of their outstanding shares is at $7.9 million. Universe Pharmaceuticals (NASDAQ:UPC) stock rose 11.62% to $1.92. The company's market cap stands at $7.0 million. Vaxxinity (NASDAQ:VAXX) shares moved upwards by 7.99% to $0.72. The company's market cap stands at $90.8 million. Unity Biotechnology (NASDAQ:UBX) stock rose 7.39% to $1.7. The market value of their outstanding shares is at $28.4 mi
Gainers Salarius Pharmaceuticals (NASDAQ:SLRX) shares rose 33.9% to $0.83 during Friday's after-market session. The market value of their outstanding shares is at $3.2 million. Masimo (NASDAQ:MASI) shares rose 12.48% to $151.77. The company's market cap stands at $8.0 billion. Vicarious Surgical (NYSE:RBOT) shares moved upwards by 11.17% to $0.38. The market value of their outstanding shares is at $66.7 million. Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 11.11% to $2.2. The company's market cap stands at $8.0 million. Psyence Biomedical (NASDAQ:PBM) stock increased by 9.09% to $1.2. The company's market cap stands at $16.0 million. Bright Green (NASDAQ:BGXX) shares ro
Gainers XTL Biopharmaceuticals (NASDAQ:XTLB) shares moved upwards by 13.9% to $2.71 during Wednesday's after-market session. The market value of their outstanding shares is at $14.7 million. Leap Therapeutics (NASDAQ:LPTX) shares rose 11.21% to $2.84. The market value of their outstanding shares is at $72.6 million. As per the press release, Q4 earnings came out 2 days ago. Jaguar Health (NASDAQ:JAGX) stock rose 10.94% to $0.09. The company's market cap stands at $18.2 million. Sharps Technology (NASDAQ:STSS) shares moved upwards by 9.73% to $0.37. The market value of their outstanding shares is at $5.6 million. Universe Pharmaceuticals (NASDAQ:UPC) shares rose 8.88% to $1.96. The compa
Gainers Ontrak (NASDAQ:OTRK) stock increased by 61.0% to $0.31 during Monday's after-market session. The company's market cap stands at $8.4 million. Universe Pharmaceuticals (NASDAQ:UPC) stock rose 30.26% to $1.98. The market value of their outstanding shares is at $7.2 million. Augmedix (NASDAQ:AUGX) shares increased by 18.61% to $3.95. The market value of their outstanding shares is at $191.7 million. As per the press release, Q4 earnings came out today. Sophia Genetics (NASDAQ:SOPH) shares moved upwards by 14.31% to $4.95. The company's market cap stands at $323.2 million. SCWorx (NASDAQ:WORX) shares moved upwards by 14.05% to $2.11. The market value of their outstanding shares is a